Hims & Hers Health, Inc.

As of June 30, 2026, Hims & Hers Health, Inc. Registered Shs A Cert Deposito Arg Repr 0.25 Shs carries a market capitalization of 11.81T, placing it among publicly traded companies globally. Its enterprise value stands at 12.85T, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Hims & Hers Health, Inc. Registered Shs A Cert Deposito Arg Repr 0.25 Shs's next confirmed earnings release is scheduled for November 9, 2026.

As of June 30, 2026, Hims & Hers Health, Inc. Registered Shs A Cert Deposito Arg Repr 0.25 Shs has 872.09M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 3.02, and the price-to-book ratio stands at 24.56.

These figures are as of June 30, 2026. The EV/Sales ratio of 3.36 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 12.85T versus a market cap of 11.81T, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Hims & Hers Health, Inc. Registered Shs A Cert Deposito Arg Repr 0.25 Shs maintains a current ratio of 0.93, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2026, Hims & Hers Health, Inc. Registered Shs A Cert Deposito Arg Repr 0.25 Shs posted a negative return on equity (ROE) of -32.03, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -5.16, reflecting losses generated across the asset base. The company generates approximately 1.71B in revenue per employee across its workforce of 2,240.75, a quick read on workforce productivity versus industry peers. Inventory turnover of 7.09 indicates how many times Hims & Hers Health, Inc. Registered Shs A Cert Deposito Arg Repr 0.25 Shs sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Hims & Hers Health, Inc. Registered Shs A Cert Deposito Arg Repr 0.25 Shs recorded an income tax benefit of -32.01B rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -242.71B and -210.70B in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

These figures are as of the close on October 22, 2026.

Over the twelve months ended June 30, 2026, Hims & Hers Health, Inc. Registered Shs A Cert Deposito Arg Repr 0.25 Shs generated 3.82T in revenue and converted that into -210.70B in net income, yielding earnings per share of -235.63. EBITDA reached -99.89B, while operating income came in at -229.23B.

As of June 30, 2026, Hims & Hers Health, Inc. Registered Shs A Cert Deposito Arg Repr 0.25 Shs holds 1.25T in cash and equivalents against 2.29T in total debt, resulting in a net debt position of 1.12T. Total book value stands at 480.76B, with working capital of -146.30B providing operational flexibility.

Hims & Hers Health, Inc. Registered Shs A Cert Deposito Arg Repr 0.25 Shs produced 390.83B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -299.39B in capital expenditures, free cash flow totaled 91.43B - equivalent to 107.10 per share.

Over the twelve months ended June 30, 2026, Hims & Hers Health, Inc. Registered Shs A Cert Deposito Arg Repr 0.25 Shs posted a gross margin of 68.43, reflecting its pricing power and cost economics. The operating margin of -5.99 and net profit margin of -5.51 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield stands at 0.76, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield is negative at -1.60, meaning Hims & Hers Health, Inc. Registered Shs A Cert Deposito Arg Repr 0.25 Shs raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, Hims & Hers Health, Inc. Registered Shs A Cert Deposito Arg Repr 0.25 Shs has an Altman Z-Score of 2.18, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.